FVCM
AVNS

F&V Capital Management’s Avanos Medical AVNS Stock Holding History

F&V Capital Management’s Portfolio AVNS Stock Details AVNS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q2 		– Sell
-4,382
Closed -$215K – 68
2015
Q1 		$215K Buy
+4,382
New +$203K 0.15% 63

Other funds holding AVNS

T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
WHG
Westwood Holdings Group Dallas, Texas $13.7B AUM 21.48% 1-Year Est. Return
RP
RR Partners New York $929M AUM 110.28% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM
CIP
Champlain Investment Partners Burlington, Vermont $7.88B AUM 6.82% 1-Year Est. Return

F&V Capital Management's AVNS Position: Q2 2015 in Review

F&V Capital Management sold out of Avanos Medical (AVNS) in Q2 2015, closing a stake of 4,382 shares — an estimated $215K sold.

F&V Capital Management first reported a position in AVNS in Q1 2015 and held it in 1 quarter. The position peaked at $215K in Q1 2015. 419 funds tracked by Wall St. Rank hold AVNS as of Q2 2015.

  • F&V Capital Management reported no remaining Avanos Medical position as of Q2 2015 after selling out during the quarter.
  • F&V Capital Management sold 4,382 Avanos Medical shares in Q2 2015, an estimated $215K.
  • F&V Capital Management first reported a position in Avanos Medical in Q1 2015 and held it in 1 quarter.
  • F&V Capital Management's Avanos Medical position peaked at $215K in Q1 2015.
  • 419 funds tracked by Wall St. Rank held Avanos Medical as of Q2 2015.

Based on F&V Capital Management's 13F filing for Q2 2015, filed 10 Jul 2015.